Scrip: industry news and insights
Healios, Athersys Confident Despite Missed Japan Stroke Endpoint
By Ian Haydock 25 May 2022
A missed primary endpoint in new top-line results from a Japanese trial with the stem cell therapy for stroke MultiStem...